Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1480914

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1480914

Glutamine

PUBLISHED:
PAGES: 94 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 5600
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 16800

Add to Cart

Global Glutamine Market to Reach $171.9 Million by 2030

The global market for Glutamine estimated at US$145.1 Million in the year 2023, is expected to reach US$171.9 Million by 2030, growing at a CAGR of 2.4% over the analysis period 2023-2030. Nutraceutical Grade Glutamine, one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$106 Million by the end of the analysis period. Growth in the Pharmaceutical Grade Glutamine segment is estimated at 2.2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $39.2 Million, While China is Forecast to Grow at 3.2% CAGR

The Glutamine market in the U.S. is estimated at US$39.2 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$31.3 Million by the year 2030 trailing a CAGR of 3.2% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2% and 2.1% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 2.2% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$21 Million by the year 2030.

Introducing Our Exciting New Report Features for 2024

Full access to influencer engagement stats

Free access to our digital archives & "MarketGlass" research platform. Our proprietary MarketGlass platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. Our state-of-art tools bring world class market perspectives while protecting participants' privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.

Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities

Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas

Complimentary report updates for one year

Competitor coverage with global market shares of major players

Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies

Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024

Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 43 Featured) -

  • Ajinomoto Group
  • Allmax Nutrition Inc
  • Battery Nutrition Limited
  • Evonik
  • hangjiagangxingyuTechnology
  • Inomoto Co. Inc.
  • Jiahe Biotech
  • JiangsuShenhua Pharmaceutical
  • Jinghai Amino Acid
  • Kyowa
  • MeihuaGroup
  • NOW Foods
  • Nutri Advanced Ltd
  • Nutritechz
  • Optimum Nutrition Inc;
Product Code: MCP17442

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Glutamine - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Glutamine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Glutamine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Glutamine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Nutraceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Nutraceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Nutraceutical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Pharmaceutical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Grades by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Other Grades by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Other Grades by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Glutamine Market Analysis of Annual Sales in US$ for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Glutamine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 16: USA 16-Year Perspective for Glutamine by Grade - Percentage Breakdown of Value Sales for Nutraceutical, Pharmaceutical and Other Grades for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for Glutamine by Grade - Percentage Breakdown of Value Sales for Nutraceutical, Pharmaceutical and Other Grades for the Years 2014, 2024 & 2030
  • JAPAN
    • Glutamine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for Glutamine by Grade - Percentage Breakdown of Value Sales for Nutraceutical, Pharmaceutical and Other Grades for the Years 2014, 2024 & 2030
  • CHINA
    • Glutamine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 25: China 16-Year Perspective for Glutamine by Grade - Percentage Breakdown of Value Sales for Nutraceutical, Pharmaceutical and Other Grades for the Years 2014, 2024 & 2030
  • EUROPE
    • Glutamine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Glutamine by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Glutamine by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Glutamine by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Glutamine by Grade - Percentage Breakdown of Value Sales for Nutraceutical, Pharmaceutical and Other Grades for the Years 2014, 2024 & 2030
  • FRANCE
    • Glutamine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 34: France 16-Year Perspective for Glutamine by Grade - Percentage Breakdown of Value Sales for Nutraceutical, Pharmaceutical and Other Grades for the Years 2014, 2024 & 2030
  • GERMANY
    • Glutamine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for Glutamine by Grade - Percentage Breakdown of Value Sales for Nutraceutical, Pharmaceutical and Other Grades for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for Glutamine by Grade - Percentage Breakdown of Value Sales for Nutraceutical, Pharmaceutical and Other Grades for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Glutamine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 43: UK 16-Year Perspective for Glutamine by Grade - Percentage Breakdown of Value Sales for Nutraceutical, Pharmaceutical and Other Grades for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 46: Spain 16-Year Perspective for Glutamine by Grade - Percentage Breakdown of Value Sales for Nutraceutical, Pharmaceutical and Other Grades for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 49: Russia 16-Year Perspective for Glutamine by Grade - Percentage Breakdown of Value Sales for Nutraceutical, Pharmaceutical and Other Grades for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of Europe 16-Year Perspective for Glutamine by Grade - Percentage Breakdown of Value Sales for Nutraceutical, Pharmaceutical and Other Grades for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Glutamine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Glutamine by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Glutamine by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Glutamine by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Glutamine by Grade - Percentage Breakdown of Value Sales for Nutraceutical, Pharmaceutical and Other Grades for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Glutamine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 61: Australia 16-Year Perspective for Glutamine by Grade - Percentage Breakdown of Value Sales for Nutraceutical, Pharmaceutical and Other Grades for the Years 2014, 2024 & 2030
  • INDIA
    • Glutamine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 64: India 16-Year Perspective for Glutamine by Grade - Percentage Breakdown of Value Sales for Nutraceutical, Pharmaceutical and Other Grades for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 67: South Korea 16-Year Perspective for Glutamine by Grade - Percentage Breakdown of Value Sales for Nutraceutical, Pharmaceutical and Other Grades for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 16-Year Perspective for Glutamine by Grade - Percentage Breakdown of Value Sales for Nutraceutical, Pharmaceutical and Other Grades for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Glutamine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Glutamine by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Glutamine by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Glutamine by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Glutamine by Grade - Percentage Breakdown of Value Sales for Nutraceutical, Pharmaceutical and Other Grades for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 79: Argentina 16-Year Perspective for Glutamine by Grade - Percentage Breakdown of Value Sales for Nutraceutical, Pharmaceutical and Other Grades for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 82: Brazil 16-Year Perspective for Glutamine by Grade - Percentage Breakdown of Value Sales for Nutraceutical, Pharmaceutical and Other Grades for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 85: Mexico 16-Year Perspective for Glutamine by Grade - Percentage Breakdown of Value Sales for Nutraceutical, Pharmaceutical and Other Grades for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Latin America 16-Year Perspective for Glutamine by Grade - Percentage Breakdown of Value Sales for Nutraceutical, Pharmaceutical and Other Grades for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Glutamine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Glutamine by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Glutamine by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Glutamine by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for Glutamine by Grade - Percentage Breakdown of Value Sales for Nutraceutical, Pharmaceutical and Other Grades for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 97: Iran 16-Year Perspective for Glutamine by Grade - Percentage Breakdown of Value Sales for Nutraceutical, Pharmaceutical and Other Grades for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 100: Israel 16-Year Perspective for Glutamine by Grade - Percentage Breakdown of Value Sales for Nutraceutical, Pharmaceutical and Other Grades for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 103: Saudi Arabia 16-Year Perspective for Glutamine by Grade - Percentage Breakdown of Value Sales for Nutraceutical, Pharmaceutical and Other Grades for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 106: UAE 16-Year Perspective for Glutamine by Grade - Percentage Breakdown of Value Sales for Nutraceutical, Pharmaceutical and Other Grades for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of Middle East 16-Year Perspective for Glutamine by Grade - Percentage Breakdown of Value Sales for Nutraceutical, Pharmaceutical and Other Grades for the Years 2014, 2024 & 2030
  • AFRICA
    • Glutamine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Glutamine by Grade - Nutraceutical, Pharmaceutical and Other Grades Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 112: Africa 16-Year Perspective for Glutamine by Grade - Percentage Breakdown of Value Sales for Nutraceutical, Pharmaceutical and Other Grades for the Years 2014, 2024 & 2030

IV. COMPETITION

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!